Prediction of spontaneous preterm birth using fetal fibronectin in women with a low-lying placenta

J Matern Fetal Neonatal Med. 2017 Feb;30(3):313-316. doi: 10.3109/14767058.2016.1171837. Epub 2016 Apr 19.

Abstract

Objective: To determine the effect of a low-lying placenta on the concentration of quantitative fetal fibronectin (qfFN) in the cervicovaginal fluid (CVF), and predictive accuracy for spontaneous preterm birth in asymptomatic high-risk women (18 + 0-24 + 0 weeks gestation).

Methods: Median concentrations of qfFN were compared in women who had a low-lying placenta, covering the cervical os (n = 61) to matched controls (n= 61) without a low-lying placenta. Proportions of women with raised qfFN concentrations (>10 ng/ml), and false positive and negative rates (FPR and FNR) for spontaneous preterm delivery were also compared.

Results: The median concentration of qfFN in women with low-lying placenta was 5.0 ng/mL, compared with 6.0 ng/mL in controls. Proportion of women with raised levels (>10 ng/mL), positive levels (>50 ng/mL) and very high levels (>200 ng/mL) were similar in both groups (62.3% versus 59.0%, 16.3% versus 22.0% and 6.5% versus 4.9%, p > 0.05 for all thresholds). The FPR and FNR rate for delivery before 34 and 37 weeks were also comparable (FPR 90.0% versus 85.7% and 80.0% versus 78.6%; FNR 5.8% versus 4.3% and 9.8% versus 8.5%).

Conclusions: CVF qfFN concentrations in asymptomatic high-risk women are not affected by the presence of a low-lying placenta.

Keywords: Fetal fibronectin; low-lying placenta; preterm birth.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • Case-Control Studies
  • Decision Support Techniques
  • False Negative Reactions
  • False Positive Reactions
  • Female
  • Fibronectins / metabolism*
  • Humans
  • Placenta Previa / metabolism*
  • Pregnancy
  • Premature Birth / diagnosis*
  • Premature Birth / etiology
  • Premature Birth / metabolism
  • Prospective Studies

Substances

  • Biomarkers
  • FFN protein, human
  • Fibronectins